Nexalin Technology (NASDAQ:NXL) Trading Down 3%

Nexalin Technology, Inc. (NASDAQ:NXL)’s share price was down 3% during mid-day trading on Thursday . The stock traded as low as $0.94 and last traded at $0.96. Approximately 153,332 shares were traded during trading, a decline of 89% from the average daily volume of 1,409,454 shares. The stock had previously closed at $0.98.

Nexalin Technology Stock Up 0.9 %

The business’s fifty day moving average price is $1.31 and its 200 day moving average price is $1.11. The firm has a market capitalization of $10.20 million, a PE ratio of -1.46 and a beta of 5.69.

Institutional Investors Weigh In On Nexalin Technology

A hedge fund recently bought a new stake in Nexalin Technology stock. CVI Holdings LLC acquired a new stake in shares of Nexalin Technology, Inc. (NASDAQ:NXL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 55,462 shares of the company’s stock, valued at approximately $94,000. CVI Holdings LLC owned 0.52% of Nexalin Technology as of its most recent SEC filing. Hedge funds and other institutional investors own 0.65% of the company’s stock.

About Nexalin Technology

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.